<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="165690">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00940888</url>
  </required_header>
  <id_info>
    <org_study_id>60020938</org_study_id>
    <nct_id>NCT00940888</nct_id>
  </id_info>
  <brief_title>SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients</brief_title>
  <official_title>SJ4 Post Approval Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterize the chronic performance of the St. Jude Medical
      SJ4 connector and RV high voltage SJ4 leads.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>RV capture thresholds</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication free survival rate related to the high voltage RV SJ4 lead or SJ4 connector</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1701</enrollment>
  <condition>Tachyarrhythmias</condition>
  <condition>Sudden Cardiac Death</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>No treatment: ICD/CRTD-indicated</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SJ4 connector and RV high voltage SJ4 lead</intervention_name>
    <description>Standard of care implantation of SJ4 device system</description>
    <arm_group_label>No treatment: ICD/CRTD-indicated</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ICD and CRTD indicated patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have an approved indication per ACC/AHA/HRS guidelines for implantation of heart
             failure or life-threatening ventricular tachyarrhythmias and will be implanted with a
             St. Jude Medical SJ4 system.

          -  Have the ability to provide informed consent for study participating and be willing
             and able to comply with the prescribed follow-up test and schedule of evaluations.

        Exclusion Criteria:

          -  Be currently participating in a clinical investigation that includes an active
             treatment arm.

          -  Have a life expectancy of less than 6 months due to any condition.

          -  Be less than 18 years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruce Wilkoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Clevleland Clinic Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <lastchanged_date>February 12, 2016</lastchanged_date>
  <firstreceived_date>July 14, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICD</keyword>
  <keyword>CRTD</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>DF4</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
